Gentex (GNTX) Cash & Equivalents (2009 - 2026)

Gentex (GNTX) has reported Cash & Equivalents for 18 consecutive years, with $164.8 million the latest figure, recorded in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $164.8 million, down 42.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $164.8 million (down 42.5% YoY), and the FY2025 annual result was $145.6 million, down 37.58% from the prior year.
• Cash & Equivalents was $164.8 million for Q1 2026 at Gentex, up from $145.6 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $286.6 million in Q1 2025 and troughed at $119.8 million in Q2 2025.
• Average Cash & Equivalents over 5 years is $220.3 million, with a median of $226.4 million recorded in 2023.
• Year-over-year, Cash & Equivalents climbed 16.91% in 2023 and tumbled 53.98% in 2025.
• Over 5 years, Cash & Equivalents stood at $214.8 million in 2022, then rose by 5.44% to $226.4 million in 2023, then increased by 3.04% to $233.3 million in 2024, then sank by 37.58% to $145.6 million in 2025, then gained by 13.12% to $164.8 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $164.8 million in Q1 2026, $145.6 million in Q4 2025, and $178.6 million in Q3 2025.